nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—forelimb—amyotrophic lateral sclerosis	0.029	0.15	CbGeAlD
Trandolapril—CES1—Phase I biotransformations, non P450—PON1—amyotrophic lateral sclerosis	0.0262	0.322	CbGpPWpGaD
Trandolapril—ACE—hindlimb—amyotrophic lateral sclerosis	0.0261	0.135	CbGeAlD
Trandolapril—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0251	0.0347	CcSEcCtD
Trandolapril—ACE—arm—amyotrophic lateral sclerosis	0.0249	0.129	CbGeAlD
Trandolapril—ACE—appendage—amyotrophic lateral sclerosis	0.0224	0.115	CbGeAlD
Trandolapril—ACE—peripheral nervous system—amyotrophic lateral sclerosis	0.0204	0.105	CbGeAlD
Trandolapril—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0263	CcSEcCtD
Trandolapril—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0188	0.026	CcSEcCtD
Trandolapril—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0233	CcSEcCtD
Trandolapril—ACE—nerve—amyotrophic lateral sclerosis	0.0159	0.0818	CbGeAlD
Trandolapril—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0217	CcSEcCtD
Trandolapril—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0215	CcSEcCtD
Trandolapril—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.0152	0.021	CcSEcCtD
Trandolapril—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0205	CcSEcCtD
Trandolapril—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0188	CcSEcCtD
Trandolapril—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0186	CcSEcCtD
Trandolapril—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0182	CcSEcCtD
Trandolapril—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0181	CcSEcCtD
Trandolapril—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.013	0.0179	CcSEcCtD
Trandolapril—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0161	CcSEcCtD
Trandolapril—Gout—Riluzole—amyotrophic lateral sclerosis	0.01	0.0138	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.01	0.123	CbGpPWpGaD
Trandolapril—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00996	0.0137	CcSEcCtD
Trandolapril—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00989	0.0137	CcSEcCtD
Trandolapril—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00936	0.0129	CcSEcCtD
Trandolapril—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00781	0.0108	CcSEcCtD
Trandolapril—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00774	0.0107	CcSEcCtD
Trandolapril—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0104	CcSEcCtD
Trandolapril—ACE—embryo—amyotrophic lateral sclerosis	0.00744	0.0383	CbGeAlD
Trandolapril—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0101	CcSEcCtD
Trandolapril—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00699	0.00965	CcSEcCtD
Trandolapril—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00696	0.00961	CcSEcCtD
Trandolapril—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00682	0.00941	CcSEcCtD
Trandolapril—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00938	CcSEcCtD
Trandolapril—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00674	0.0093	CcSEcCtD
Trandolapril—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00669	0.00923	CcSEcCtD
Trandolapril—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00646	0.00891	CcSEcCtD
Trandolapril—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00627	0.00866	CcSEcCtD
Trandolapril—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00614	0.00847	CcSEcCtD
Trandolapril—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00601	0.0083	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00599	0.00827	CcSEcCtD
Trandolapril—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00591	0.00816	CcSEcCtD
Trandolapril—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00794	CcSEcCtD
Trandolapril—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00789	CcSEcCtD
Trandolapril—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00565	0.00779	CcSEcCtD
Trandolapril—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00558	0.00769	CcSEcCtD
Trandolapril—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00758	CcSEcCtD
Trandolapril—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00749	CcSEcCtD
Trandolapril—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00746	CcSEcCtD
Trandolapril—CES1—nervous system—amyotrophic lateral sclerosis	0.00537	0.0277	CbGeAlD
Trandolapril—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00536	0.0074	CcSEcCtD
Trandolapril—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00722	CcSEcCtD
Trandolapril—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00722	CcSEcCtD
Trandolapril—Depression—Riluzole—amyotrophic lateral sclerosis	0.00522	0.0072	CcSEcCtD
Trandolapril—CES1—central nervous system—amyotrophic lateral sclerosis	0.00517	0.0266	CbGeAlD
Trandolapril—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00712	CcSEcCtD
Trandolapril—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00708	CcSEcCtD
Trandolapril—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00702	CcSEcCtD
Trandolapril—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00693	CcSEcCtD
Trandolapril—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00495	0.00683	CcSEcCtD
Trandolapril—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00681	CcSEcCtD
Trandolapril—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00674	CcSEcCtD
Trandolapril—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0066	CcSEcCtD
Trandolapril—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0065	CcSEcCtD
Trandolapril—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00649	CcSEcCtD
Trandolapril—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00645	CcSEcCtD
Trandolapril—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00644	CcSEcCtD
Trandolapril—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0064	CcSEcCtD
Trandolapril—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00639	CcSEcCtD
Trandolapril—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00637	CcSEcCtD
Trandolapril—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00636	CcSEcCtD
Trandolapril—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00613	CcSEcCtD
Trandolapril—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00606	CcSEcCtD
Trandolapril—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00602	CcSEcCtD
Trandolapril—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00588	CcSEcCtD
Trandolapril—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00586	CcSEcCtD
Trandolapril—ACE—spinal cord—amyotrophic lateral sclerosis	0.00424	0.0218	CbGeAlD
Trandolapril—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00585	CcSEcCtD
Trandolapril—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00579	CcSEcCtD
Trandolapril—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00415	0.00573	CcSEcCtD
Trandolapril—SLC15A2—medulla oblongata—amyotrophic lateral sclerosis	0.00414	0.0214	CbGeAlD
Trandolapril—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00568	CcSEcCtD
Trandolapril—CES1—brain—amyotrophic lateral sclerosis	0.0041	0.0211	CbGeAlD
Trandolapril—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00565	CcSEcCtD
Trandolapril—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00556	CcSEcCtD
Trandolapril—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00553	CcSEcCtD
Trandolapril—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00546	CcSEcCtD
Trandolapril—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00543	CcSEcCtD
Trandolapril—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00524	CcSEcCtD
Trandolapril—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00522	CcSEcCtD
Trandolapril—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00519	CcSEcCtD
Trandolapril—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00516	CcSEcCtD
Trandolapril—SLC15A2—spinal cord—amyotrophic lateral sclerosis	0.00369	0.019	CbGeAlD
Trandolapril—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00509	CcSEcCtD
Trandolapril—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00507	CcSEcCtD
Trandolapril—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00506	CcSEcCtD
Trandolapril—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00505	CcSEcCtD
Trandolapril—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00499	CcSEcCtD
Trandolapril—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00496	CcSEcCtD
Trandolapril—ACE—nervous system—amyotrophic lateral sclerosis	0.00357	0.0184	CbGeAlD
Trandolapril—Cough—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00493	CcSEcCtD
Trandolapril—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00481	CcSEcCtD
Trandolapril—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00481	CcSEcCtD
Trandolapril—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00481	CcSEcCtD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00348	0.0427	CbGpPWpGaD
Trandolapril—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00479	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00477	CcSEcCtD
Trandolapril—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00475	CcSEcCtD
Trandolapril—ACE—central nervous system—amyotrophic lateral sclerosis	0.00344	0.0177	CbGeAlD
Trandolapril—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0047	CcSEcCtD
Trandolapril—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00461	CcSEcCtD
Trandolapril—Infection—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00458	CcSEcCtD
Trandolapril—Shock—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00453	CcSEcCtD
Trandolapril—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00452	CcSEcCtD
Trandolapril—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00451	CcSEcCtD
Trandolapril—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00326	0.0045	CcSEcCtD
Trandolapril—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00448	CcSEcCtD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00323	0.0396	CbGpPWpGaD
Trandolapril—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00445	CcSEcCtD
Trandolapril—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00439	CcSEcCtD
Trandolapril—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00431	CcSEcCtD
Trandolapril—SLC15A2—nervous system—amyotrophic lateral sclerosis	0.00311	0.0161	CbGeAlD
Trandolapril—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0042	CcSEcCtD
Trandolapril—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00417	CcSEcCtD
Trandolapril—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.003	0.00414	CcSEcCtD
Trandolapril—SLC15A2—central nervous system—amyotrophic lateral sclerosis	0.003	0.0155	CbGeAlD
Trandolapril—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00411	CcSEcCtD
Trandolapril—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0041	CcSEcCtD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00296	0.0363	CbGpPWpGaD
Trandolapril—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00406	CcSEcCtD
Trandolapril—SLC15A2—cerebellum—amyotrophic lateral sclerosis	0.00293	0.0151	CbGeAlD
Trandolapril—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00401	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00398	CcSEcCtD
Trandolapril—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00397	CcSEcCtD
Trandolapril—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00394	CcSEcCtD
Trandolapril—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0038	CcSEcCtD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00275	0.0337	CbGpPWpGaD
Trandolapril—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00377	CcSEcCtD
Trandolapril—ACE—brain—amyotrophic lateral sclerosis	0.00273	0.0141	CbGeAlD
Trandolapril—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00366	CcSEcCtD
Trandolapril—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00364	CcSEcCtD
Trandolapril—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00364	CcSEcCtD
Trandolapril—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00339	CcSEcCtD
Trandolapril—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00331	CcSEcCtD
Trandolapril—SLC15A2—brain—amyotrophic lateral sclerosis	0.00238	0.0123	CbGeAlD
Trandolapril—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00326	CcSEcCtD
Trandolapril—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00315	CcSEcCtD
Trandolapril—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00305	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.0022	0.027	CbGpPWpGaD
Trandolapril—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00293	CcSEcCtD
Trandolapril—Rash—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00291	CcSEcCtD
Trandolapril—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0029	CcSEcCtD
Trandolapril—Headache—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00289	CcSEcCtD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00205	0.0251	CbGpPWpGaD
Trandolapril—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00274	CcSEcCtD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.0019	0.0233	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00183	0.0225	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00174	0.0214	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00162	0.0198	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00161	0.0198	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00139	0.017	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00127	0.0156	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00124	0.0153	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00105	0.0129	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00102	0.0126	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000986	0.0121	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000973	0.0119	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000916	0.0112	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000866	0.0106	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00085	0.0104	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000779	0.00955	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000729	0.00894	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000723	0.00886	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000722	0.00886	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000694	0.00851	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00067	0.00822	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000644	0.0079	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00062	0.0076	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000465	0.00571	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000458	0.00561	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000432	0.0053	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000396	0.00485	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000396	0.00485	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000367	0.0045	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000367	0.0045	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000353	0.00433	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000327	0.00401	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000193	0.00237	CbGpPWpGaD
